Merck Profit Beats Analysts Estimates on Diabetes Drug Sales

Merck Profit Beats Analysts Estimates on Diabetes Drug Sales

JB Reed/ Bloomberg

Sales of the diabetes medications Januvia and Janumet increased 5 percent to $1.5 billion.